
To compare efficacy of zzso zzso 22 zzso or 44 zzso weekly, with zzso in zzso zzso 

zzso exists concerning the optimal dose regimen for zzso beta in zzso zzso Many patients and physicians prefer the convenience and lesser side effects of an injection given once weekly zzso as opposed to three times zzso zzso data and information on zzso markers suggest that this frequency may be zzso 

zzso zzso study of zzso zzso 22 zzso 44 zzso or zzso administered by weekly subcutaneous injection for 48 zzso zzso density zzso and zzso zzso scans during 24 weeks of therapy were analyzed for the number of combined unique zzso zzso zzso zzso zzso zzso scans were analyzed for zzso activity and burden of disease zzso 

zzso zzso at 24 weeks had a median of zzso with zzso zzso with 22 zzso (not zzso and zzso with 44 zzso zzso zzso zzso zzso new zzso zzso zzso at 48 weeks was zzso for zzso zzso for 22 zzso zzso zzso zzso and zzso for 44 zzso zzso zzso zzso zzso at 48 weeks showed a median increase of zzso for zzso compared with a decrease of zzso in the 44 zzso group zzso zzso zzso and zzso in the 22 zzso group zzso zzso zzso No clinical zzso apart from steroid use in the 44 zzso zzso group zzso zzso zzso showed zzso 

These data confirm an zzso benefit of zzso zzso at low dose in zzso but highlight the limited clinical zzso Taken together with other studies, the data demonstrate a zzso relationship for both clinical and zzso zzso 

